We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




New Endoscopic Approach Relieves Gastroparesis Symptoms

By HospiMedica International staff writers
Posted on 24 Sep 2018
Per-oral pyloromyotomy (POP), an endoscopic intramural treatment for gastroparesis, significantly improves patient symptoms and gastric emptying, according to a new study.

Researchers at the Cleveland Clinic (CC; OH, USA) and Case Western Reserve University (CWRU; Cleveland, OH, USA) conducted a retrospective study to compare all 30 patients who underwent laparoscopic pyloroplasty (LP) for treatment of gastroparesis with those undergoing POP from October 2014 through September 2017. More...
Patients were matched on a 1:1 basis, based on gender, age, and etiology of gastroparesis, which was 63.3% idiopathic, 20.0% post-surgical, and 16.7% diabetic (in both cohorts).

The results revealed that patients who underwent LP had an almost triple average length of stay and estimated blood loss than those that underwent POP. There were more overall complications in the LP cohort than in the POP one (16.7 versus. 3.3%, respectively), including surgical site infection (6.7 versus 0%), pneumonia (6.7% versus 0%), and unplanned ICU admission (10% versus 0%). LP and POP both resulted in similar, significant improvements in both in gastroparesis cardinal symptom index (GCSI) scores and objective gastric emptying. The study was published on July 17, 2018, in Surgical Endoscopy.

“When you compare the results in terms of symptom improvement and the complication rate of this as a new procedure, we’re doing much better than every other option that we have for patients with gastroparesis,” said senior author John Rodriguez, MD, director of surgical endoscopy at the Cleveland Clinic. “The procedure is very safe, and there were no procedure-related adverse events, including gastric or duodenal ulcer, intraluminal hemorrhage, or gastric dumping syndrome.”

Gastroparesis, a delayed gastric emptying in the absence of mechanical obstruction, is a debilitating and chronic digestive disease affecting five million people in the U.S. alone. Surgical options are few: gastric electrical stimulation, gastric emptying procedures, gastric diversion or gastric resection. POP is a less invasive method of disrupting the pylorus; the technique involves an initial mucosotomy to create a submucosal tunnel up to the duodenal bulb, followed by a myotomy of the circular fibers of the pylorus. The mucosotomy is subsequently closed with clips.

Related Links:
Cleveland Clinic
Case Western Reserve University


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Multi-Chamber Washer-Disinfector
WD 390
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image: The findings suggest that hematopoietic cell transplantation may benefit patients with Shwachman-Diamond syndrome soon after high-risk features are detected, before advanced malignancy develops. (Image Credit: Shutterstock)

Early Stem Cell Transplantation May Improve Survival in Rare Inherited Bone Marrow Disorder

Shwachman-Diamond syndrome (SDS) is a rare inherited bone marrow disorder that can progress to severe hematologic disease. More than 90% of affected children survive beyond age 20, but fewer than 30% live... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.